4//SEC Filing
Duker Jay S. 4
Accession 0001562180-25-005074
CIK 0001314102other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:13 PM ET
Size
6.9 KB
Accession
0001562180-25-005074
Insider Transaction Report
Form 4
Duker Jay S.
DirectorPresident and CEO
Transactions
- Other
Common Stock
2025-06-23$8.21/sh−56,665$465,220→ 986 total
Holdings
- 99,165(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares were sold by the reporting person to the Duker Family 2024 Irrevocable Trust, or the Family Trust, in exchange for a promissory note in the principal amount of $465,219.65, representing the fair market value as determined by utilizing the average of the high and low per share trading price on the date of the sale. The shares held in the Family Trust are for the benefit of the reporting person's children. The reporting person's spouse is a trustee of the Family Trust. The reporting person disclaims beneficial ownership of the security and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001630864
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:13 PM ET
- Size
- 6.9 KB